Oriola Oyj Earnings Estimate

Oriola Oyj Earnings per Share Projection vs Actual

About Oriola Oyj Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Oriola Oyj earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Oriola Oyj estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Oriola Oyj fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Oriola Oyj provides healthcare and wellbeing products in Sweden, Finland, and internationally.The company offers various range of OTC and traded good, vitamins, dietary supplements, pharmaceutical cosmetics, skincare products, tests, sports drinks, and wound care products. The company was formerly known as Oriola-KD Oyj and changed its name to Oriola Oyj in April 2017. ORIOLA OYJ operates under Pharmaceutical Retailers classification in Germany and is traded on Frankfurt Stock Exchange. It employs 2768 people.

Currently Active Assets on Macroaxis

Other Information on Investing in Oriola Stock

Oriola Oyj financial ratios help investors to determine whether Oriola Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Oriola with respect to the benefits of owning Oriola Oyj security.